Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06496568
Title A Study Evaluating Single-agent Inavolisib and Inavolisib Plus Atezolizumab in PIK3CA-Mutated Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
University of Alabama at Birmingham Comprehensive Cancer Center WITHDRAWN Birmingham Alabama 35249 United States Details
Moores Cancer Center at UC San Diego Health RECRUITING La Jolla California 92093 United States Details
California Cancer Associates for Research & Excellence, Inc. RECRUITING San Marcos California 92069 United States Details
Vanderbilt-Ingram Cancer Ctr RECRUITING Nashville Tennessee 37232 United States Details
BC Cancer Vancouver Centre RECRUITING Vancouver British Columbia V5Z 4E6 Canada Details
Princess Margaret Cancer Center RECRUITING Toronto Ontario M5G 2M9 Canada Details
Jewish General Hospital RECRUITING Montreal Quebec H3T 1E2 Canada Details
Seoul National University Hospital ACTIVE_NOT_RECRUITING Seoul 03080 Korea, Republic of Details
Samsung Medical Center RECRUITING Seoul 06351 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field